While globalization, an aging population, and economic forces are pushing the trend toward personalized medicine, the US healthcare system is slow to adopt it, probably as a result of some combination of the financial issue mentioned in the Introduction, politics, regulation, economics, and ethics, rather than science — which, as we show in other sections […]